Cutando A, López-Valverde A, Gómez-de-Diego
R, Arias-Santiago S, de Vicente-Jiménez J. Effect of gingival application of
melatonin on alkaline and acid phosphatase, osteopontin and osteocalcin in
patients with diabetes and periodontal disease. Med Oral Patol Oral
Cir Bucal. 2013 Jul 1;18 (4):e657-63.
doi:10.4317/medoral.18832
http://dx.doi.org/doi:10.4317/medoral.18832
|
1. Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B, et al. A longitudinal study of various crevicular fluid components as markers of periodontal
disease activity. J Clin
Periodontol. 1996;23:832-38. |
|
|
|
|
|
2. Dabra S, Singh P. Evaluating the levels
of salivary alkaline and acid phosphatase
activities as biochemical markers for periodontal disease: A case series.
Dent Res J (Isfahan). 2012;9:41-5. |
|
|
|
|
|
3.Perinetti G, Paolantonio M, Femminella B, Serra E, Spoto,
G. Gingival crevicular fluid alkaline phosphatase activity reflects periodontal
healing/recurrent inflammation phases in chronic periodontitis
patients. J Periodontol.
2008;79:1200-7. |
|
|
|
|
|
4. Gibert
P, Tramini P, Sieso V, Piva
MT. Alkaline
phosphatase isozyme
activity in serum from patients with chronic periodontitis.
J Periodont Res. 2003;38:362-5. |
|
|
|
|
|
5. Talonpoika JT, Hämäläinen
MM. Type I collagen carboxyterminal telopeptide in human gingival crevicular
fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol.
1994;21:320-6. |
|
|
|
|
|
6. Lee AJ, Walsh TF, Hodges SJ, Rawlinson A. Gingival crevicular fluid osteocalcin in
adult periodontitis. J Clin Periodontol.
1999;26:252-6. |
|
|
|
|
|
7. Eley BM, Cox SW. Advances in periodontal
diagnosis. 10. Potential markers of bone resorption.
Br Dent J. 1998;184:489-92. |
|
|
|
|
|
8. Kido
J, Nakamura T, Asahara Y,
Sawa T, Kohri K, Nagata T. Osteopontin in
gingival crevicular fluid. J Periodontal
Res. 2001;36:328-33. |
|
|
|
|
|
9. Bowers MR, Fisher LW, Termine JD, Somerman MJ. Connective tissue-associated proteins in crevicular fluid: potential markers for periodontal
diseases. J Periodontol.
1989;60:448-51. |
|
|
|
|
|
10. Bullon
P, Goberna B, Guerrero JM, Segura JJ, Perez-Cano R, Martinez-Sahuquillo
A. Serum, saliva, and gingival crevicular
fluid osteocalcin: their relation to periodontal
status and bone mineral density
in postmenopausal women.
J Periodontol. 2005;76:513-9. |
|
|
|
|
|
11. Sharma CG, Pradeep AR. Gingival crevicular fluid osteopontin
levels in periodontal health and disease. J
Periodontol. 2006;77:1674-80. |
|
|
|
|
|
12. Reiter RJ, Tan DX, Manchester LC, Qi W.
Biochemical reactivity of melatonin with reactive oxygen and nitrogen
species: a review of the evidence. Cell Biochem Biophys. 2001;34:237-56. |
|
|
|
|
|
13. Radogna F, Diederich
M, Ghibelli L. Melatonin: a pleiotropic
molecule regulating inflammation. Biochem
Pharmacol. 2010;80:1844-52. |
|
|
|
|
|
14. Cardinali DP, Ladizesky
MG, Boggio V, Cutrera RA,
Mautalen C. Melatonin effects on bone: experimental
facts and clinical perspectives. J
Pineal Res. 2003;34:81-7. |
|
|
|
|
|
15. Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, et al. Melatonin
promotes osteoblastic differentiation through the
BMP/ERK/Wnt signaling pathways. J Pineal Res. 2011;51:187-94. |
|
|
|
|
|
16. Cutando
A, Gómez-Moreno G, Arana C, Acu-a-Castroviejo C, Reiter RJ. Melatonin: potential functions in the oral cavity. J
Periodontol. 2007;78:1094-102. |
|
|
|
|
|
17. Gómez-Moreno G,
Guardia J, Ferrera MJ, Cutando
A, Reiter RJ. Melatonin in diseases of the
oral cavity. Oral Dis. 2010;16:242-7. |
|
|
|
|
|
18. Cutando A, Gómez-Moreno
G, Villalba J, Ferrera
MJ, Escames G, Acu-a-Castroviejo
D. Relationship between salivary melatonin levels and periodontal status in
diabetic patients. J Pineal Res. 2003;35:239-44. |
|
|
|
|
|
19. Cutando
A, Galindo P, Gómez-Moreno G, Arana C, Bola-os J, Acu-a-Castroviejo
D, et al. Relationship between salivary melatonin and severity of periodontal
disease. J Periodontol. 2006;77:1533-8. |
|
|
|
|
|
20. Daltaban O, Saygun
I, Bal B, Baloş K, Serdar M. Gingival crevicular
fluid alkaline phosphatase levels in postmenopausal
women: effects of phase I periodontal treatment. J Periodontol. 2006;77:67-72. |
|
|
|
|
|
21. Giannobile WV. Crevicular
fluid biomarkers of oral bone loss. Curr Opin Periodontol. 1997;4:11-20. |
|
|
|
|
|
22. Giannobile WV, Al-Shammari
KF, Sarment DP. Matrix molecules and growth factors
as indicators of periodontal disease activity. Periodontol 2000. 2003;31:125-34. |
|
|
|
|
|
23. Bullon P, Chandler L, Segura Egea JJ, Perez Cano R, Martinez Sahuquillo
A. Osteocalcin in serum, saliva and gingival crevicular fluid: their relation with periodontal
treatment outcome in postmenopausal women. Med
Oral Patol Oral Cir Bucal. 2007;12:E193-7. |
|
|
|
|
|
24. Becerik S, Afacan
B, Oztürk VÖ, Atmaca H, Emingil G. Gingival crevicular
fluid calprotectin, osteocalcin
and cross-linked N-terminal telopeptid levels in
health and different periodontal diseases. Dis Markers. 2011;31:343-52. |
|
|
|
|
|
25. Sharma CG, Pradeep AR. Plasma and crevicular fluid osteopontin
levels in periodontal health and disease. J Periodont
Res. 2007;42:450-5. |
|
|
|
|
|
26. Lakschevitz F, Aboodi
G, Tenenbaum H, Glogauer
M. Diabetes and periodontal diseases: interplay and links. Curr Diabetes Rev. 2011;7:433-9. |
|
|
|
|
|
27. Nomura
Y, Tamaki Y, Tanaka T, Arakawa H, Tsurumoto A, Kirimura K, et al. Screening of periodontitis with salivary enzyme tests. J Oral Sci.
2006;48:177-83. |
|
|
|
|
|
28 Gómez-Moreno G, Cutando-Soriano A, Arana C, Galindo P, Bola-os J, Acu-a-Castroviejo D, et al. Melatonin expression in
periodontal disease. J Periodont Res. 2007;42:536-40. |
|
|
|
|
|
29. Srinath R, Acharya
AB, Thakur SL. Salivary and gingival crevicular fluid melatonin in periodontal health and
disease. J Periodontol.
2010;81:277-83. |
|